Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosa.

[1]  Leonard Leibovici,et al.  β lactam monotherapy versus β lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials , 2004, BMJ : British Medical Journal.

[2]  E. Giamarellos‐Bourboulis,et al.  Pharmacokinetic interactions of ceftazidime, imipenem and aztreonam with amikacin in healthy volunteers. , 2004, International journal of antimicrobial agents.

[3]  C. van Delden,et al.  Effectiveness of Combination Antimicrobial Therapy for Pseudomonas aeruginosa Bacteremia , 2003, Antimicrobial Agents and Chemotherapy.

[4]  W. Craig.  Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid. , 2003, Infectious disease clinics of North America.

[5]  H. Kitasato,et al.  Pretreatment of Pseudomonas aeruginosa with a sub-MIC of imipenem enhances bactericidal activity of neutrophils , 2003, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[6]  T. Tamaya,et al.  Pharmacokinetics of single-dose intravenous ciprofloxacin in blood and ascites of patients with pelvic peritonitis , 2003, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[7]  H. Bruining,et al.  Pharmacokinetics of ceftazidime in serum and peritoneal exudate during continuous versus intermittent administration to patients with severe intra-abdominal infections. , 2002, The Journal of antimicrobial chemotherapy.

[8]  B. Mishra,et al.  Postantibiotic Effect of a Combination of Antimicrobial Agents on Pseudomonas aeruginosa , 2000, Chemotherapy.

[9]  R. Li,et al.  Impact of pharmacokinetics on the postantibiotic effect exhibited by Pseudomonas aeruginosa following tobramycin exposure: application of an in-vitro model. , 1998, The Journal of antimicrobial chemotherapy.

[10]  H. Verbrugh,et al.  Duration and Clinical Relevance of Postantibiotic Effect in Relation to the Dosing Interval , 1998, Antimicrobial Agents and Chemotherapy.

[11]  E. Giamarellos‐Bourboulis,et al.  Interactions of Ceftazidime and Amikacin on Multiresistant Pseudomonas aeruginosa , 1998, Clinical drug investigation.

[12]  E. Giamarellos‐Bourboulis,et al.  Comparative in vitro interactions of ceftazidime, meropenem, and imipenem with amikacin on multiresistant Pseudomonas aeruginosa. , 1997, Diagnostic microbiology and infectious disease.

[13]  J. Turnidge,et al.  The postantibiotic effect of imipenem: relationship with drug concentration, duration of exposure, and MIC , 1997, Antimicrobial agents and chemotherapy.

[14]  R. Wise,et al.  Postantibiotic effect of trovafloxacin on Pseudomonas aeruginosa. , 1997, The Journal of antimicrobial chemotherapy.